Price Alert

Maze Therapeutics Inc. (MAZE)

NASDAQ: MAZE · Real-Time Price · USD

13.49

0.14 (1.05%)

At close: Aug 15, 2025, 3:59 PM

13.50

0.07%

After-hours: Aug 15, 2025, 05:38 PM EDT

Maze Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Net Income	-33.68M	-32.79M	-29.58M	-24.75M	139.06M	-32.49M	-26.58M	-24.75M
Depreciation & Amortization	649K	684K	705K	788K	854K	950K	976K	1M
Stock-Based Compensation	3.24M	3.23M	2.85M	2.34M	2.14M	2.31M	2.56M	2.11M
Other Working Capital	-2.31M	-2M	210K	-4.06M	2.04M	492K	-2.22M	206K
Other Non-Cash Items	779K	785K	2.54M	3.65M	567K	5.55M	4.65M	695K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.04M	-1.43M	1.03M	-5.23M	2.43M	249K	-2.25M	963K
Operating Cash Flow	-30.05M	-29.52M	-22.45M	-23.2M	145.05M	-23.44M	-20.64M	-19.97M
Capital Expenditures	-393K	-299K	-605K	-103K	-160K	-279K	-34K	3K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-393K	-299K	-605K	-103K	-160K	-279K	-34K	3K
Debt Repayment	n/a	n/a	-16.18M	n/a	259K	24.22M	16.18M	n/a
Common Stock Repurchased	612K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-374K	16.18M	-2.15M	-105K	n/a	n/a	8K
Financial Cash Flow	612K	127.38M	70.26M	-2.15M	154K	24.58M	16.19M	8K
Net Cash Flow	-29.83M	97.56M	47.2M	-25.46M	145.04M	865K	-4.49M	-19.96M
Free Cash Flow	-30.45M	-29.82M	-23.06M	-23.31M	144.89M	-23.72M	-20.68M	-19.97M